Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Different skin diseases show unique patterns of skin cell separation, cell death, and granular layer changes.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Proper education can prevent traction alopecia in women of color.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Children's skin diseases and treatments differ from adults and require specific approaches.

Improved nutrition quickly healed the patient's skin lesions.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Antibiotics often cause skin reactions, making them a major health concern.